SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-044005
Filing Date
2021-08-12
Accepted
2021-08-12 16:25:53
Documents
3
Period of Report
2021-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pstx-8k_20210812.htm 8-K 34460
2 EX-99.1 pstx-ex991_6.htm EX-99.1 151725
3 GRAPHIC gq1kbwlpxdts000001.jpg GRAPHIC 752068
  Complete submission text file 0001564590-21-044005.txt   1201625
Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100
Poseida Therapeutics, Inc. (Filer) CIK: 0001661460 (see all company filings)

IRS No.: 472846548 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39376 | Film No.: 211167949
SIC: 2836 Biological Products, (No Diagnostic Substances)